dc.contributor.author | Cunningham, Yvonne | |
dc.contributor.author | Wood, Karen | |
dc.contributor.author | Stewart, Carrie | |
dc.contributor.author | Nakham, Athagran | |
dc.contributor.author | Newlands, Rumana | |
dc.contributor.author | Gallacher, Katie I. | |
dc.contributor.author | Quinn, Terence J | |
dc.contributor.author | Ellis, Graham | |
dc.contributor.author | Lowrie, Richard | |
dc.contributor.author | Myint, Phyo Kyaw | |
dc.contributor.author | Bond, Christine | |
dc.contributor.author | Mair, Frances S. | |
dc.date.accessioned | 2022-01-06T15:39:01Z | |
dc.date.available | 2022-01-06T15:39:01Z | |
dc.date.issued | 2021-11-12 | |
dc.identifier.citation | Cunningham , Y , Wood , K , Stewart , C , Nakham , A , Newlands , R , Gallacher , K I , Quinn , T J , Ellis , G , Lowrie , R , Myint , P K , Bond , C & Mair , F S 2021 , ' Understanding stakeholder views regarding the design of an intervention trial to reduce anticholinergic burden : a qualitative study ' , Frontiers in Pharmacology , vol. 12 , 608208 . https://doi.org/10.3389/fphar.2021.608208 | en |
dc.identifier.issn | 1663-9812 | |
dc.identifier.other | PURE: 189790354 | |
dc.identifier.other | PURE UUID: 80a535ac-572a-4f58-9a6c-6f3127bc906e | |
dc.identifier.other | PubMed: 34867311 | |
dc.identifier.other | PubMedCentral: PMC8633300 | |
dc.identifier.other | Scopus: 85120429261 | |
dc.identifier.uri | https://hdl.handle.net/2164/17796 | |
dc.description | Funding statement This research was supported by the Chief Scientist Office under their Catalytic Research Grants Scheme, CSO reference number: CGA/18/47. Acknowledgments We gratefully acknowledge the support from the Alliance, the Glasgow Stroke Group and NKS in recruiting focus group participants and conducting the focus groups and Scottish Primary Care Research Network for recruiting patients from primary care. Special thanks to Irene Oldfather from Alliance and Naseem Suleman from NKS for their help in setting up interviews and focus groups. We gratefully acknowledge the research participants who provided their views and insights. | en |
dc.format.extent | 10 | |
dc.language.iso | eng | |
dc.relation.ispartof | Frontiers in Pharmacology | en |
dc.rights | © 2021 Cunningham, Wood, Stewart, Nakham, Newlands, Gallacher, Quinn, Ellis, Lowrie, Myint, Bond and Mair. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. https://creativecommons.org/licenses/by/4.0/ | en |
dc.subject | anticholinergics | en |
dc.subject | Deprescribing | en |
dc.subject | Polypharmacy | en |
dc.subject | interviews | en |
dc.subject | Focus Groups | en |
dc.subject | Qualitative Research | en |
dc.subject | R Medicine | en |
dc.subject | Chief Scientist Office (CSO) | en |
dc.subject | CGA/18/47 | en |
dc.subject | Supplementary Information | en |
dc.subject.lcc | R | en |
dc.title | Understanding stakeholder views regarding the design of an intervention trial to reduce anticholinergic burden : a qualitative study | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Health Services Research Unit | en |
dc.contributor.institution | University of Aberdeen.Medicine, Medical Sciences & Nutrition | en |
dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Publisher PDF | en |
dc.identifier.doi | https://doi.org/10.3389/fphar.2021.608208 | |
dc.identifier.vol | 12 | en |